Medical Condition News

RSS

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.

3 May 2010

Protein test to determine response of lung cancer patients to erlotinib

Testing for the presence of specific cancer protein 'fingerprints' in the blood of lung cancer patients may be a useful means of identifying a subgroup whose tumors are more likely to shrink when treated with the drug erlotinib, especially when other testing methods are unavailable, according to new data presented at the 2nd European Lung Cancer Conference in Geneva, Switzerland.

3 May 2010

New classification of depressive subtypes of depression proposed

Lichtenberg and Belmaker propose a new classification of depressive subtypes of depression in the current issue of Psychotherapy and Psychosomatics. They argue that a simple diagnosis is no longer sufficient to guide treatment.

3 May 2010

Scripps Research Institute awarded grant to design assays for exploring potential target for obesity, Type 2 diabetes

The Scripps Research Institute has been awarded a $1.3 million grant by the National Institutes of Health (NIH) to develop a series of tests at its Florida campus to help explore the potential of a protein that has emerged as a highly attractive target for the treatment of obesity and Type 2 diabetes.

3 May 2010

Investigators examine effects of family-oriented interventions on adults with chronic physical diseases

In the current issue of Psychotherapy and Psychosomatics a group of German investigators examines the literature concerned with the effects of interventions involving the family in the treatment of patients with chronic disease.

3 May 2010

Pfizer to maintain top spot in prescription sales through mergers and acquisitions

The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech analysis.

3 May 2010

Triple combination therapy with OM, AML, HCTZ more effective at lowering blood pressure

Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components).

3 May 2010

Pay-for-performance policies may create financial disincentives for doctors to treat obese patients

Pay-for-performance reimbursement of surgeons, intended to reward doctors and hospitals for good patient outcomes, may instead be creating financial incentives for discriminating against obese patients, who are much more likely to suffer expensive complications after even the most routine surgeries, according to new Johns Hopkins research.

3 May 2010

Study finds servicemen and women at increased risk for suicide

When young servicemen and women return home from a tour of duty, their family and friends breathe a sigh of relief, knowing their loved ones finally are safe and sound. New research, however, shows that is not always the case.

3 May 2010

Celgene seeks court declaration over claims of romidepsin injection usage for T-cell lymphomas

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.

3 May 2010

EHR with controlled interventions can produce optimal BP control, reduce mortality

Electronic health records with controlled interventions can produce optimal blood pressure control and reduce mortality, according to data presented at the American Society of Hypertension Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010).

3 May 2010

Promising results from combination therapy of pemetrexed concurrent with radiation in lung cancer

The first trial of an important new combination therapy of treatment with the chemotherapy drug pemetrexed concurrent with radiation in lung cancer has delivered promising results, French researchers report at the 2nd European Lung Cancer Conference.

3 May 2010

Study shows link between short cycles of sleep, stroke and SCI in elderly hypertensive patients

Data presented today at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition demonstrate a link between short cycles of sleep, stroke and silent cerebral infarct, or "silent strokes," in elderly hypertensive patients.

3 May 2010

CML, FightSMA Canada collaborate to find a cure for spinal muscular atrophy

CML HealthCare Income Fund (TSX: CLC.UN), (CML) of Mississauga, Ontario has partnered with FightSMA Canada, to help find a cure for Spinal Muscular Atrophy (SMA), the leading genetic cause of death among children under the age of two.

3 May 2010

AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia

AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.

3 May 2010

BSGI improves breast cancer detection

A new study, presented at the American Society of Breast Surgeons Annual Meeting in Las Vegas, found that Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of breast cancers to neoadjuvant chemotherapy.

3 May 2010

Exposure to violent crime may exacerbate asthma in children

Exposure to violent crime may exacerbate asthma in children, according to a study to be presented Saturday, May 1 at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.

3 May 2010

Left ventricular mass may help predict future cardiovascular and renal outcomes: Study

Data presented today at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010) indicate that in men with high cardiovascular risk, left ventricular mass may help better predict future cardiovascular and renal outcomes, including hemodialysis.

3 May 2010

Scientific validity of traditional Chinese medicine for pain treatment receives support

The scientific validity of traditional Chinese medicine for pain treatment of pain received a nod of support in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

3 May 2010

BioMedica Diagnostics’ flagship product monitors heart disease

BioMedica Diagnostics Inc, a company that uses innovative technology to link the medical needs of developed countries with those of less advantaged populations is growing.

3 May 2010

Medical Condition News

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Protein test to determine response of lung cancer patients to erlotinib

New classification of depressive subtypes of depression proposed

Scripps Research Institute awarded grant to design assays for exploring potential target for obesity, Type 2 diabetes

Investigators examine effects of family-oriented interventions on adults with chronic physical diseases

Pfizer to maintain top spot in prescription sales through mergers and acquisitions

Triple combination therapy with OM, AML, HCTZ more effective at lowering blood pressure

Pay-for-performance policies may create financial disincentives for doctors to treat obese patients

Study finds servicemen and women at increased risk for suicide

Celgene seeks court declaration over claims of romidepsin injection usage for T-cell lymphomas

EHR with controlled interventions can produce optimal BP control, reduce mortality

Promising results from combination therapy of pemetrexed concurrent with radiation in lung cancer

Study shows link between short cycles of sleep, stroke and SCI in elderly hypertensive patients

CML, FightSMA Canada collaborate to find a cure for spinal muscular atrophy

AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia

BSGI improves breast cancer detection

Exposure to violent crime may exacerbate asthma in children

Left ventricular mass may help predict future cardiovascular and renal outcomes: Study

Scientific validity of traditional Chinese medicine for pain treatment receives support

BioMedica Diagnostics’ flagship product monitors heart disease

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Latest News